Clinical and paraclinical guidelines for management of sulfur mustard induced bronchiolitis obliterans; from bench to bedside

References

• Aghanouri R, Ghanei M, Aslani J, Keivani-Amine H, Rastegar F, Karkhane A. 2004. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 287:L1160–L1164.
   PubMed Web of Science ®Google Scholar
• Akira M, Toyokawa K, Inoue Y, Arai T. 2009. Quantitative CT in chronic obstructive pulmonary disease: inspiratory and expiratory assessment. AJR Am J Roentgenol 192:267–272.
   PubMed Web of Science ®Google Scholar
• Amiri S, Ghazanfari T, Yaraee R, Salimi H, Ebtekar M, Shams J, Ghasemi H, Pourfarzam S, Moin A, Sharifnia Z, Soroush MR, Faghihzadeh S, Hassan ZM. 2009. Serum levels of GM-CSF 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1499–1503.
   PubMed Web of Science ®Google Scholar
• Attaran D, Lari SM, Khajehdaluee M, Ayatollahi H, Towhidi M, Asnaashari A, Marallu HG, Mazloomi M, Mood MB. 2009. Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases. Hum Exp Toxicol 28:739–745.
   PubMed Web of Science ®Google Scholar
• Bagheri MH, Hosseini SK, Mostafavi SH, Alavi SA. 2003. High-resolution CT in chronic pulmonary changes after mustard gas exposure. Acta Radiol 44:241–245.
   PubMed Web of Science ®Google Scholar
• Balali-Mood M, Hefazi M, Mahmoudi M, Jalali E, Attaran D, Maleki M, Razavi ME, Zare G, Tabatabaee A, Jaafari MR. 2005. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 19:713–721.
   PubMed Web of Science ®Google Scholar
• Balali-Mood M, Hefazi M. 2006. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 99:273–282.
   PubMed Web of Science ®Google Scholar
• Basseri B, Enayati P, Marchevsky A, Papadakis KA. 2010. Pulmonary manifestations of inflammatory bowel disease: case presentations and review. J Crohns Colitis 4:390–397.
   PubMed Web of Science ®Google Scholar
• Beheshti J, Mark EJ, Akbaei HM, Aslani J, Ghanei M. 2006. Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract 202:739–744.
   PubMed Web of Science ®Google Scholar
• Bijani Kh, Moghadamnia AA. 2002. Long-term effects of chemical weapons on respiratory tract in Iraq-Iran war victims living in Babol (North of Iran). Ecotoxicol Environ Saf 53:422–424.
   PubMed Web of Science ®Google Scholar
• Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, Walz A. 1994. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 149:655–659.
   PubMed Web of Science ®Google Scholar
• Chan A, Allen R. 2004. Bronchiolitis obliterans: an update. Curr Opin Pulm Med 10:133–141.
   PubMed Web of Science ®Google Scholar
• Colby TV. 1998. Bronchiolitis. Pathologic considerations. Am J Clin Pathol 109:101–109.
   PubMed Web of Science ®Google Scholar
• Danilko KV, Korytina GF, Akhmidishina LZ, Ianbaeva DG, Zagidullin ShZ, Victorova TV. 2007. [Association of cytokines genes (ILL, IL1RN, TNF, LTA, IL6, IL8, IL0) polymorphic markers with chronic obstructive pulmonary disease]. Mol Biol (Mosk) 41:26–36.
   PubMed Web of Science ®Google Scholar
• Dirksen A. 2008. Is CT a new research tool for COPD? Clin Respir J 2 Suppl 1:76–83.
   PubMedGoogle Scholar
• Dompeling E, Jöbsis Q, Vandevijver NM, Wesseling G, Hendriks H. 2004. Chronic bronchiolitis in a 5-yr-old child after exposure to sulphur mustard gas. Eur Respir J 23:343–346.
   PubMed Web of Science ®Google Scholar
• Dosreis GA, Borges VM, Zin WA. 2004. The central role of Fas-ligand cell signaling in inflammatory lung diseases. J Cell Mol Med 8:285–293.
   PubMed Web of Science ®Google Scholar
• Egan JJ. 2004. Obliterative bronchiolitis after lung transplantation: a repetitive multiple injury airway disease. Am J Respir Crit Care Med 170:931–932.
   PubMed Web of Science ®Google Scholar
• El-Gamel A, Sim E, Hasleton P, Hutchinson J, Yonan N, Egan J, Campbell C, Rahman A, Sheldon S, Deiraniya A, Hutchinson IV. 1999. Transforming growth factor β (TGF-β) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 18:828–837.
   PubMed Web of Science ®Google Scholar
• Emad A, Emad Y. 2007. Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. J Interferon Cytokine Res 27:38–43.
   PubMed Web of Science ®Google Scholar
• Emad A, Rezaian GR. 1997. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 112:734–738.
   PubMed Web of Science ®Google Scholar
• Emad A, Rezaian GR. 1999. Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 115:1346–1351.
   PubMed Web of Science ®Google Scholar
• Essadki O, Grenier P. 1999. [Bronchiolitis: computed tomographic findings]. J Radiol 80:17–24.
   PubMedGoogle Scholar
• Estenne M, Hertz MI. 2002. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 166:440–444.
   PubMed Web of Science ®Google Scholar
• Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. 2002. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21:297–310.
   PubMed Web of Science ®Google Scholar
• Garg K, Lynch DA, Newell JD, King TE Jr. 1994. Proliferative and constrictive bronchiolitis: classification and radiologic features. AJR Am J Roentgenol 162:803–808.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Akhlaghpoor S, Moahammad MM, Aslani J. 2004a. Tracheobronchial stenosis following sulfur mustard inhalation. Inhal Toxicol 16:845–849.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Fathi H, Mohammad MM, Aslani J, Nematizadeh F. 2004b. Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol 16:491–495.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Mokhtari M, Mohammad MM, Aslani J. 2004c. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol 52:164–169.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Hosseini AR, Arabbaferani Z, Shahkarami E. 2005a. Evaluation of chronic cough in chemical chronic bronchitis patients. Environ Toxicol Pharmacol 20:6–10.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Khalili AR, Arab MJ, Mojtahedzadeh M, Aslani J, Lessan-Pezeshki M, Panahi Y, Alaeddini F. 2005b. Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin Pharmacol Toxicol 97:302–305.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Akbari Moqadam F, Mohammad MM, Aslani J. 2006a. Tracheobronchomalacia and air trapping after mustard gas exposure. Am J Respir Crit Care Med 173:304–309.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Khedmat H, Mardi F, Hosseini A. 2006b. Distal esophagitis in patients with mustard-gas induced chronic cough. Dis Esophagus 19:285–288.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Amiri S, Akbari H, Kosari F, Khalili AR, Alaeddini F, Aslani J, Giardina C, Haines DD. 2007a. Correlation of sulfur mustard exposure and tobacco use with expression (immunoreactivity) of p53 protein in bronchial epithelium of Iranian “mustard lung” patients. Mil Med 172:70–74.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Harandi AA. 2007b. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 19:451–456.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Tazelaar HD, Harandi A, Peyman M, Hoseini Akbari HM, Aslani J. 2007c. Clinical differentiation between resistant asthma and chronic bronchiolitis: testing a practical approach. Iran J Allergy Asthma Immunol 6:207–214.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Tazelaar HD, Chilosi M, Harandi AA, Peyman M, Akbari HM, Shamsaei H, Bahadori M, Aslani J, Mohammadi A. 2008. An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med 102:825–830.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Harandi AA. 2011. Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review. Inhal Toxicol 23:363–371.
   PubMed Web of Science ®Google Scholar
• Ghazanfari T, Sharifnia Z, Yaraee R, Pourfarzam S, Kariminia A, Mahlojirad M, Faghihzadeh S, Jalali-Nodoushan MR, Ardestani SK, Soroush MR, Amiri S, Hassan ZM, Ghavami S, Ghanei M. 2009. Serum soluble Fas ligand and nitric oxide in long-term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1489–1493.
   PubMed Web of Science ®Google Scholar
• Gosink BB, Friedman PJ, Liebow AA. 1973. Bronchiolitis obliterans. Roentgenologic-pathologic correlation. Am J Roentgenol Radium Ther Nucl Med 117:816–832.
   PubMedGoogle Scholar
• Hassan ZM, Ebtekar M, Ghanei M, Taghikhani M, Noori Daloii MR, Ghazanfari T. 2006. Immunobiological consequences of sulfur mustard contamination. Iran J Allergy Asthma Immunol 5:101–108.
   PubMedGoogle Scholar
• Hefazi M, Attaran D, Mahmoudi M, Balali-Mood M. 2005. Late respiratory complications of mustard gas poisoning in Iranian veterans. Inhal Toxicol 17:587–592.
   PubMed Web of Science ®Google Scholar
• Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. 1998. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 17:1255–1263.
   PubMed Web of Science ®Google Scholar
• Hwang JH, Kim TS, Lee KS, Choi YH, Han J, Chung MP, Kwon OJ, Rhee CH. 1997. Bronchiolitis in adults: pathology and imaging. J Comput Assist Tomogr 21:913–919.
   PubMed Web of Science ®Google Scholar
• Jafari M, Ghanei M. 2010. Evaluation of plasma, erythrocytes, and bronchoalveolar lavage fluid antioxidant defense system in sulfur mustard-injured patients. Clin Toxicol (Phila) 48:184–192.
   PubMed Web of Science ®Google Scholar
• Kaditis AG, Gondor M, Nixon PA, Webber S, Keenan RJ, Kaye R, Kurland G. 2000. Airway complications following pediatric lung and heart-lung transplantation. Am J Respir Crit Care Med 162:301–309.
   PubMed Web of Science ®Google Scholar
• Kang EY, Woo OH, Shin BK, Yong HS, Oh YW, Kim HK. 2009. Bronchiolitis: classification, computed tomographic and histopathologic features, and radiologic approach. J Comput Assist Tomogr 33:32–41.
   PubMed Web of Science ®Google Scholar
• Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. 2003. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45:1136–1143.
   PubMed Web of Science ®Google Scholar
• Law L, Zheng L, Orsida B, Levvey B, Oto T, Kotsimbos AT, Snell GI, Williams TJ. 2005. Early changes in basement membrane thickness in airway walls post-lung transplantation. J Heart Lung Transplant 24:1571–1576.
   PubMed Web of Science ®Google Scholar
• Lee TM, Lin MS, Chang NC. 2008. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol 101:530–535.
   PubMed Web of Science ®Google Scholar
• Mehrani H, Ghanei M, Aslani J, Golmanesh L. 2009. Bronchoalveolar lavage fluid proteomic patterns of sulfur mustard-exposed patients. Proteomics Clin Appl 3:1191–1200.
   PubMed Web of Science ®Google Scholar
• Mirsadraee M, Attaran D, Boskabady MH, Towhidi M. 2005. Airway hyperresponsiveness to methacholine in chemical warfare victims. Respiration 72:523–528.
   PubMedGoogle Scholar
• Mroz BJ, Sexauer WP, Meade A, Balsara G. 1997. Hemoptysis as the presenting symptom in bronchiolitis obliterans organizing pneumonia. Chest 111:1775–1778.
   PubMed Web of Science ®Google Scholar
• Müller NL, Miller RR. 1995. Diseases of the bronchioles: CT and histopathologic findings. Radiology 196:3–12.
   PubMed Web of Science ®Google Scholar
• Myers JL, Colby TV. 1993. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med 14:611–622.
   PubMed Web of Science ®Google Scholar
• Myers PO, Gasche-Soccal PM, Robert JH, Pache JC, Bongiovanni M. 2009. Neuroendocrine proliferation after lung transplantation. J Heart Lung Transplant 28:406–408.
   PubMed Web of Science ®Google Scholar
• Nash EF, Volling C, Gutierrez CA, Tullis E, Coonar A, McRae K, Keshavjee S, Singer LG, Durie PR, Chaparro C. 2012. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis. Clin Transplant 26:34–41.
   PubMed Web of Science ®Google Scholar
• Nocker RE, Schoonbrood DF, van de Graaf EA, Hack CE, Lutter R, Jansen HM, Out TA. 1996. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 109:183–191.
   PubMed Web of Science ®Google Scholar
• Pourfarzam S, Ghazanfari T, Yaraee R, Ghasemi H, Hassan ZM, Faghihzadeh S, Ardestani SK, Kariminia A, Fallahi F, Soroush MR, Merasizadeh J, Mahlojirad M, Naghizadeh MM, Ghanei M. 2009. Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1482–1488.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Myers JL, Swensen SJ. 2003. Bronchiolar disorders. Am J Respir Crit Care Med 168:1277–1292.
   PubMed Web of Science ®Google Scholar
• Scott AI, Sharples LD, Stewart S. 2005. Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies. Drugs 65:761–771.
   PubMed Web of Science ®Google Scholar
• Shohrati M, Shamspour N, Babaei F, Harandi AA, Mohsenifar A, Aslani J, Ghanei M. 2010. Evaluation of activity and phenotype of α1-antitrypsin in a civil population with respiratory complications following exposure to sulfur mustard 20 years ago. Biomarkers 15:47–51.
   PubMed Web of Science ®Google Scholar
• Skeens JL, Fuhrman CR, Yousem SA. 1989. Bronchiolitis obliterans in heart-lung transplantation patients: radiologic findings in 11 patients. AJR Am J Roentgenol 153:253–256.
   PubMed Web of Science ®Google Scholar
• Sohrabpour H. 1984. Clinical manifestations of chemical agents on Iranian combatants during Iran-Iraq conflict. Arch Belg Suppl:291–297.
   PubMedGoogle Scholar
• Stanbrook MB, Kesten S. 1999. Bronchial hyperreactivity after lung transplantation predicts early bronchiolitis obliterans. Am J Respir Crit Care Med 160:2034–2039.
   PubMed Web of Science ®Google Scholar
• Stern EJ, Frank MS. 1994. Small-airway diseases of the lungs: findings at expiratory CT. AJR Am J Roentgenol 163:37–41.
   PubMed Web of Science ®Google Scholar
• Sweatman MC, Millar AB, Strickland B, Turner-Warwick M. 1990. Computed tomography in adult obliterative bronchiolitis. Clin Radiol 41:116–119.
   PubMed Web of Science ®Google Scholar
• Thomason JW, Rice TW, Milstone AP. 2003. Bronchiolitis obliterans in a survivor of a chemical weapons attack. JAMA 290:598–599.
   PubMed Web of Science ®Google Scholar
• Visscher DW, Myers JL. 2006. Bronchiolitis: the pathologist’s perspective. Proc Am Thorac Soc 3:41–47.
   PubMedGoogle Scholar
• Webb WR, Stein MG, Finkbeiner WE, Im JG, Lynch D, Gamsu G. 1988. Normal and diseased isolated lungs: high-resolution CT. Radiology 166:81–87.
   PubMed Web of Science ®Google Scholar
• Wohl ME, Chernick V. 1978. State of the art: bronchiolitis. Am Rev Respir Dis 118:759–781.
   PubMed Web of Science ®Google Scholar
• Yaraee R, Ghazanfari T, Ebtekar M, Ardestani SK, Rezaei A, Kariminia A, Faghihzadeh S, Mostafaie A, Vaez-Mahdavi MR, Mahmoudi M, Naghizadeh MM, Soroush MR, Hassan ZM. 2009. Alterations in serum levels of inflammatory cytokines (TNF, IL-1α, IL-1β and IL-1Ra) 20 years after sulfur mustard exposure: Sardasht-Iran cohort study. Int Immunopharmacol 9:1466–1470.
   PubMed Web of Science ®Google Scholar
• Zarchi K, Akbar A, Naieni KH. 2004. Long-term pulmonary complications in combatants exposed to mustard gas: a historical cohort study. Int J Epidemiol 33:579–581.
   PubMed Web of Science ®Google Scholar